An updated guideline on the management of dyslipidemias has been published by the European Society of Cardiology and European Atherosclerosis Society.
MUNICH, Germany—Radial access, the use of drug-eluting stents for any PCI, and revascularization— preferably surgery—for any patient with the combination of coronary artery disease, heart failure, and ...
Please provide your email address to receive an email when new articles are posted on . PARIS — The European Society of Cardiology released five new guidelines, which introduce fresh recommendations ...
AstraZeneca today announced that ticagrelor, an oral antiplatelet medicine, received a Class I recommendation from the European Society of Cardiology (ESC) in the revised “Guidelines on the Management ...
Hypertrophic cardiomyopathy (HCM), a genetic form of heart disease with thick heart walls, is the most common cause of sudden death in patients under 50. While only a minority of patients with HCM are ...
The European Society of Cardiology released today new Guidelines for the Management of Stable Angina Pectoris. The updated Guidelines include information on new developments in cardiovascular care, ...
AMSTERDAM, the Netherlands—New developments over the last 8 years have provided the impetus for revamped guidelines on the management of infective endocarditis (IE) from the European Society of ...
BRILINTA (ticagrelor) 90mg tablets by AstraZeneca The European Society of Cardiology (ESC) has given Brilinta (ticagrelor tablets; AstraZeneca) a Class I recommendation in its updated "Guidelines on ...
Sophia Antipolis, France, 22 March 2005: The European Society of Cardiology (ESC) releases the first European Guidelines on Percutaneous Coronary Interventions (PCI), pre-published and accessible on ...
The European Society of Cardiology (ESC) Guidelines for the diagnosis and treatment of acute and chronic heart failure are published online today in European Heart Journal. This was the first ESC ...
The 2020 European Society for Cardiology (ESC) guidelines for the management of adult congenital heart disease (ACHD) provide new concepts and important revisions to the previous guidelines, issued a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results